Should Cytochrome P450 Inducers be Used to Accelerate Clearance of Brodifacoum from Poisoned Patients?
I. Rubinstein; R. van Breemen; D.G. Nosal; G. Weinberg; R.C. Hershow; D.L. Feinstein
(2019) Drugs R D 19: 67-71
Omega-3 fatty acids and nonalcoholic fatty liver disease in adults and children: where do we stand?
M.H. Spooner; D.B. Jump
(2019) Curr Opin Clin Nutr Metab Care 22: 103-110
Mitochondrial complex I inhibitor deguelin induces metabolic reprogramming and sensitizes vemurafenib-resistant BRAF mutation bearing metastatic melanoma cells.
E.L. Carpenter; S. Chagani; D. Nelson; P.B. Cassidy; M. Laws; G. Ganguli-Indra; A.K. Indra
(2019) Mol. Carcinog. (accessible online)
Neuroprotective effect of CuATSM on neurotoxin-induced motor neuron loss in an ALS mouse model.
M.T.H. Kuo; J.S. Beckman; C.A. Shaw
(2019) Neurobiol. Dis. 130: 104495
Sulforaphane Bioavailability and Chemopreventive Activity in Men Presenting for Biopsy of the Prostate Gland: A Randomized Controlled Trial.
Z. Zhang; M. Garzotto; E.W. Davis; M. Mori; W.A. Stoller; P.E. Farris; C.P. Wong; L.M. Beaver; G.V. Thomas; D.E. Williams; R.H. Dashwood; D.A. Hendrix; E. Ho; J. Shannon
(2019) Nutr Cancer 1-14

Pages

More Publications